Beluga Group PAO (BELU)
Moscow Exchange · Russia · prices in RUB · close of 22 Oct 2026
Key indicators
| Last close | RUB 268.60 |
|---|---|
| 52-week range | 202.40 – 451.20 |
| Return, 1 month / 3 months | +6.6% / +17.0% |
| Return, 1 year / 3 years | −30.3% / −93.5% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -53.6% |
| Average daily value traded | 109.22M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Beluga Group is a Russian producer and distributor of alcoholic drinks based in Moscow. The company makes and markets vodka under its Beluga brand and other spirits, and it also runs a chain of wine and spirits shops serving retail customers across Russia. Its business combines drinks production with wholesale and retail distribution, giving it a presence in both manufacturing and the consumer retail market for alcohol in its home country.
Beluga Group PAO trades under the code BELU on the Moscow Exchange in Russia, with its price quoted in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Beluga Group PAO (BELU) trades on the Moscow Exchange in Russia. It last closed at RUB 268.60 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 172 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.3% and over the last three months it rose 17.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.6% | ||
| From 52-week high | -39.8% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 17.0% | ||
| 6-month return | -30.4% | ||
| 12-month return, skipping the last month | -34.6% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.6% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 109.22M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +6.6% |
| 3 months | +17.0% |
| 6 months | −30.4% |
| 1 year | −30.3% |
| 3 years | −93.5% |
| 5 years | −86.8% |
Signals
| 50-day / 200-day average | 255.61 / 329.97 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2024 | RUB 145.3700 |
| 26 Apr 2024 | RUB 316.2600 |
| 23 Jan 2024 | RUB 94.6000 |
| 13 Oct 2023 | RUB 189.1500 |
| 29 Sep 2023 | RUB 320.0000 |
| 17 Jun 2023 | RUB 87.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.